Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes: An Analysis of Data From the SAVOR Study

NCT01192659 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01192659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01192659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes: An Analysis of Data From the SAVOR Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
December 31, 2015
Enrollment
16,492 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2